Convening the extraordinary general meeting of shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Convening the extraordinary general meeting of shareholders of AB Klaip?dos Baldai

Following the decision of the board of 2014-01-03 of AB Klaip?dos Baldai (legal entity code 140656052, registered address Klaip?da city municipality, Klaip?da city, Jonišk?s g. 21, registered in the Register of Legal Entities (hereinafter referred to as the Company), the extraordinary general meeting of shareholders is being convened.

The date, time and place of the extraordinary meeting of the Company’s shareholders: 30 January 2014 (date) at 11.00am (time) in the Company's headquarters at Jonišk?s g. 21, Klaip?da. Registration of shareholders starts at 10.00am (time).

Only the persons who are the shareholders of the Company at the end of the accounting date of the extraordinary general meeting of the Company’s shareholders on 23 January 2014 (date) shall have the right to attend the extraordinary general meeting of the Company’s shareholders.

Agenda of the Meeting:

1. Regarding the Company's stock delisting from the supplementary list of AB NASDAQ OMX Vilnius stock exchange and suspension of public offer of  the Company's shares.

2. Regarding the person submitting the mandatory official offer.

The Company does not offer the shareholders to attend the meeting by electronic means of communication.

The agenda of the meeting may be amended by the supervisory board, the board or by the shareholders who hold at least 1/20 of votes carried by shares. Along with the offer, the shareholders are required submit to the Company draft resolutions on the proposed issues of their gender or, when it is not mandatory to adopt resolutions, explanatory notes on each proposed issue of the agenda of the general meeting of shareholders. The proposal to amend the agenda of the meeting must be submitted in writing by registered mail to the Company's registered address. The agenda of the meeting shall be supplemented where the proposal is received no later than 14 days before the date of the general meeting of shareholders.

The shareholders holding the shares to at least 1/20 of all votes have the right to propose new draft decisions on the issues included to the agenda of the meeting, to propose additional candidates to the members of the management bodies of the Company, and the audit firm. The proposed draft decisions must be made ??in writing by sending them by registered mail at the above mentioned Company's address.

The shareholders also have the right to propose draft resolutions on the issues of the agenda of the meeting during the meeting.

The shareholders have the right to submit questions to the Company related to the agenda items, in writing, stating in the letter the shareholder's personal ID number and sending these questions by registered mail. The Company undertakes to answer if the questions are received no later than 3 working days before the general meeting of shareholders.

The shareholder or a person authorised to participate in the meeting and entitled to vote in it, is required to furnish the ID document.

Each shareholder to have the right according to the laws to authorize another person (natural or legal person) to attend the meeting and vote on behalf of that shareholder.

At the meeting, the representative shall have the same rights as the shareholder represented, unless the representative is issued a power of attorney or where the law limits the mandate rights. The authorized person must provide the power of attorney confirmed according to the laws. A power of attorney issued abroad must be translated into Lithuanian and legalized in the manner prescribed by law.

A shareholder or his authorised person may vote in advance in writing by filling in a general ballot paper. If a shareholder wishes, the Company no later than in 10 days before the meeting, shall send the ballot paper by registered mail free of charge. The completed ballot paper and the document confirming the right to vote must be submitted to the Company in writing, no later than on the last working day before the meeting, by sending them at the above mentioned Company's address by registered mail.

The shareholders may be given access to the documents regarding the convening of the meeting and its agenda, draft decisions of each item of the agenda, the documents to be submitted to the meeting, the voting ballot form and other information related to the implementation of the shareholder’s rights, at the headquarters of AB Klaip?dos Baldai at Jonišk?s g. 21, Klaip?da and partially on the Company's web page at http://www.klaipedosbaldai.lt. Information by telephone: 370 46 313935.

AB Klaip?dos Baldai

Director

Vidas Mišeikis

For supplementary information contact:

Public Relations agency „KPMS ir partneriai“ partner

Frederikas Jansonas

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 50

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 36

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 67

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 46

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 109

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 73

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading

Top 5 Most Recently Viewed Articles

LandingAI's Significant Achievement at Snowflake Conference

Updated Category News Views 140

LandingAI Recognized as Partner of the Year LandingAI has received notable recognition at the Snowflake annual user conference for its exceptional contributions to the data cloud landscape. This acknowledgement highlights how LandingAI not only stands out in the tech industry but also pushes the boundaries of what's possible with artificial intelligence and data...

Continue Reading
Aventura Mall Tops USA Shopping Malls Again in 2026

Updated Category News Views 22

A Second Victory for Aventura Mall Well, folks, here we are again; Aventura Mall has pulled it off for a second consecutive year, grabbing the coveted 'Best Mall in the United States' title from the esteemed USA Today 10Best Readers’ Choice Awards. Now, before you roll your eyes, let's acknowledge that this ain't just a shiny plaque on the wall; it's a testament to how...

Continue Reading
Critical Metals Corp Reveals $3 Billion Valuation for Tanbreez Project

Updated Category News Views 500

Insights into Critical Metals Corp’s Tanbreez Project Critical Metals Corp (NASDAQ: CRML) recently announced an independent Preliminary Economic Assessment (PEA) for its renowned Tanbreez Project, located in Southern Greenland. This project stands out as one of the world's largest rare earth deposits, boasting a significant mineral resource of 4.7 billion metric tons of...

Continue Reading
Salesforce's Promising Future: What Investors Need to Know

Updated Category News Views 100

Salesforce's Resilient Position Amid Economic Shifts As investors navigate the current economic landscape, many are focused intently on immediate data rather than the implications for the future. With an election looming and a new earnings season underway, there's much to consider. The timeout on interest rate deliberations further complicates the financial scene, as the...

Continue Reading
Exciting Announcements for Garden Centres Canada Summit 2025

Updated Category News Views 131

Garden Centres Canada Summit 2025: An Overview The Canadian Nursery Landscape Association (CNLA) is excited to announce the upcoming Garden Centres Canada Summit 2025. This highly anticipated event will take place in Winnipeg, uniting garden centre operators, retail professionals, and industry leaders. Event Details and Schedule The Garden Centres Canada Summit is a...

Continue Reading